Medical device design and manufacturing company Kelyniam Global Inc has acquired MED-ALLY, LLC as part of its product diversification initiative. MED-ALLY applies custom, proprietary neuromodulation technology to create a number of external and implantable medical devices that can be used to treat a wide array of conditions including sleep apnea, chronic pain management, urinary incontinence, epilepsy, and Parkinson’s disease.

“Kelyniam’s mission is to develop and manufacture medical devices that significantly improve medical care, surgical outcomes, and patient quality of life, and our acquisition of MED-ALLY greatly enhances our ability to do just that,” says Tennyson Anthony, president and CEO of Kelyniam Global, in a release.